BioWorld

Aug. 29, 2003

View Archived Issues

Amgen, Genentech Legal War Ends With Payout Settlement

Exploring Brain Neurons In Rats, Fish Rebuts Dogma That Memory Molecules Consolidate Only Once

As IPO Market Improves, Aderis Tries Again, Now Seeking $75M

Holiday notice

Berlex Planning Phase III Study Of Leukine In Crohn's Patients

Other News To Note

Corrections

Myogen Raises $40M Privately, Then Registers For $70M IPO

Falling in step with others in the industry, Myogen Inc. Thursday afternoon said it registered for an initial public offering, estimating it would raise $75 million. (BioWorld Today) Read More

Today's news in brief

BioWorld

BioWorld briefs for April 7, 2026.

Hengrui discovers new Nav1.8 blockers

BioWorld Science

Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...

News in brief

BioWorld Asia

BioWorld Asia briefs for April 7, 2026

Hematopoietic stem cell research points to leukemia’s early roots

BioWorld Science

Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...

Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis

BioWorld Science

Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...